Skip to main content
  • Genotype-Guided P2Y12 Inhibitor Therapy Reduces Cumulative Ischemic Events Post-PCI: TAILOR-PCI Prespecified Analysis

    Genotype-guided antiplatelet management after percutaneous coronary intervention (PCI) reduces cumulative ischemic events at 1 year without a significant increase in bleeding events, according to new study findings.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details